Dr. Kratochvil to lead Big Ten task force for emerging infectious diseases
The Big Ten Conference Monday formally announced the formation and membership of its first-ever Task Force for Emerging Infectious Diseases. Read more
Sasha
Animal Health in the Heartland Request for Presentations
Submissions will be accepted April 20 – May 8 on IowaBio’s website. Read more
Life Sciences on the Links Rescheduled for 2021
To ensure the safety of our participants and guests, we have rescheduled our May 28, 2020 Life Sciences on the Links golf tournament to May 27, 2021. Read more
PHRMA Highlights Industry Work on COVID-19
PhRMA – Our nation’s pharmaceutical industry, including many of Bio Nebraska’s own members, is working collectively to combat COVID-19 across the globe. Bio Nebraska member, PhRMA, highlights that work. Read more
Pfizer Advances Battle Against COVID-19 on Multiple Fronts
NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) today announced important advances in the battle against the global COVID-19 pandemic. Read more
Hand sanitizer for health care produced at Nebraska Innovation Campus
The University of Nebraska–Lincoln is partnering with the Nebraska ethanol industry to produce hand sanitizer for use by hospitals, nursing homes, doctors’ offices and other health care providers in Nebraska and nearby areas. Read more
The BIO International Convention is Going Digital
For 2020, the BIO International Convention (June 8-12) will transition to a new, virtual event format, BIO Digital. Read more
Hudl’s Empowered Workforce Takes Sports Analytics to the World
We talked to Hudl about their company-wide commitment to women in STEM, as well as Diversity, Equity, and Inclusion. Read more
Member Spotlight: Streck
In this month’s member spotlight, Streck responds to local and global needs during the COVID-19 pandemic. Read more
Johnson & Johnson CEO announces vaccine candidate with high degree of probability
Alex Gorsky, chairman and CEO of Johnson & Johnson, one of several companies that’s developed a potential coronavirus vaccine, tells TODAY that his company has a candidate “that has a high degree of probability of being successful.” He anticipates starting tests in humans in September …